Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
2.560
+0.040 (1.59%)
Aug 14, 2025, 2:11 PM - Market open

Revelation Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
5.176.511.995.251.274.49
Cash & Short-Term Investments
5.176.511.995.251.274.49
Cash Growth
-57.15%-45.80%128.28%312.09%-71.63%-
Prepaid Expenses
0.190.070.080.070.640.13
Other Current Assets
--0.070.09--
Total Current Assets
5.366.5712.155.411.914.62
Property, Plant & Equipment
0.040.060.070.090.13-
Total Assets
5.46.6212.215.52.044.62
Accounts Payable
0.830.781.360.550.60.87
Accrued Expenses
0.741.131.150.991.530.34
Current Portion of Leases
----0.02-
Other Current Liabilities
003.052.91--
Total Current Liabilities
1.571.915.564.452.141.21
Total Liabilities
1.571.915.564.452.141.21
Common Stock
000000
Additional Paid-In Capital
48.8345.2132.1126.414.425.54
Retained Earnings
-45-40.51-25.47-25.35-14.52-2.53
Total Common Equity
3.834.716.651.05-0.13.01
Shareholders' Equity
3.834.716.651.05-0.13.41
Total Liabilities & Equity
5.46.6212.215.52.044.62
Total Debt
----0.02-
Net Cash (Debt)
5.176.511.995.251.264.49
Net Cash Growth
-57.15%-45.80%128.28%317.57%-72.00%-
Net Cash Per Share
15.91113.68----
Filing Date Shares Outstanding
1.70.30.03---
Total Common Shares Outstanding
1.530.17----
Working Capital
3.794.656.580.96-0.233.41
Book Value Per Share
2.4927.05----
Tangible Book Value
3.834.716.651.05-0.13.01
Tangible Book Value Per Share
2.4927.05----
Machinery
-0.150.130.130.13-
Updated Aug 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q